F2G
Mike is one of the original members of the F2G scientific staff and has been instrumental in the development of F2G’s core MycoBank® technology. Mike has over fifteen years of research experience in commercial and academic laboratories, predominantly working on Aspergillus and pathogenic fungi. Over this period he has developed a wide network of contacts in the fungal research community. His research interests include molecular epidemiology, fungal pathogenesis and intracellular signalling.
This person is not in any offices
F2G
1 followers
F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.